Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.352 Factor de Impacto de 5 años: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

Comprar Publicación $188.00 Volumen 30, 2010 Edición 3

DOI: 10.1615/CritRevImmunol.v30.i3

Tabla de Contenidos:

Development of Safe and Effcacious Viral Vaccines for Animals
Tilahun Yilma, Paulo Verardi, Leslie Jones
pages 223-237
DOI: 10.1615/CritRevImmunol.v30.i3.10
Proteomics for the Development of Vaccines and Therapeutics
Vito G. DelVecchio, Mark A. Sabato, Jessica Trichilo, Clarissa Dake, Paul Grewal, Tim Alefantis
pages 239-254
DOI: 10.1615/CritRevImmunol.v30.i3.20
New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors
Roy Curtiss III, Wei Xin, Yuhua Li, Wei Kong, Soo-Young Wanda, Bronwyn Gunn, Shifeng Wang
pages 255-270
DOI: 10.1615/CritRevImmunol.v30.i3.30
Sensitive Molecular Diagnostic Assays to Mitigate the Risks of Asymptomatic Bacterial Diseases of Plants
N. W. Schaad, E. Schuenzel
pages 271-275
DOI: 10.1615/CritRevImmunol.v30.i3.40
Analysis of Early Host Responses for Asymptomatic Disease Detection and Management of Specialty Crops
Abhaya M. Dandekar, Federico Martinelli, Cristina E. Davis, Abhinav Bhushan, Weixiang Zhao, Oliver Fiehn, Kirsten Skogerson, Gert Wohlgemuth, Raissa D'Souza, Soumen Roy, Russell L. Reagan, Dawei Lin, R. Bruce Cary, Paige Pardington, Goutam Gupta
pages 277-289
DOI: 10.1615/CritRevImmunol.v30.i3.50
Modeling the Viral Dynamics of Influenza A Virus Infection
Amber M. Smith, Ruy M. Ribeiro
pages 291-298
DOI: 10.1615/CritRevImmunol.v30.i3.60
The Intertwining of Structure and Function: Proposed Helix-Swapping of the SH2 Domain of Grb7, A Regulatory Protein Implicated in Cancer Progression and Inflammation
Sally Pias, Tabitha A. Peterson, Dennis L. Johnson, Barbara A. Lyons
pages 299-304
DOI: 10.1615/CritRevImmunol.v30.i3.70
Genome-Wide Association Studies and Infectious Disease
Anne M. Bowcock
pages 305-309
DOI: 10.1615/CritRevImmunol.v30.i3.80

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling